About Us
Additional Content
2000
Baxa celebrates its 25-Year Anniversary, emphasizing its focus on service and innovation, at the ASHP Mid-Year exhibit in Las Vegas, Nevada.Baxa UK expands its facilities to separate office, administration and warehousing activities.
2001
The ExactaMix™ 600 Universal Pump is enhanced with the release of 32-Bit Direct-Entry Software featuring user-friendly graphics and menus.Next-generation TPN-PC™ and TPN-PC Plus™ Software is released, incorporating user-directed changes for enhancing safety and efficiency for TPN compounding and calculation.
CALCTPN™ Software is released, providing a calculation foundation for health management system software packages.
Baxa introduces new logo and tagline. Technology for Solutions reinforces the company’s position as the industry leader for fluid handling technology and creating true solutions for pharmacy needs.
2002
The ExactaMix™ 2400 Compounder is introduced, offering state-of-the-art technology for multi-source solution compounding.2003
The RapidFill™ Automated Syringe Filler is introduced, the first system designed to automate sterile batch filling in the pharmacy, which minimizes the potential for contamination and reduces pharmacy overhead.Abacus® – Windows®-based order entry and calculation software for TPN compounding – introduced.
Baxa signs agreement with Carmel Pharma to become the exclusive US distributor of the PhaSeal® products, a closed system for safe handling of hazardous drugs.
Baxa opens new 93,000 ft2 headquarters facility in suburban Denver, with an 8,000 ft2 ISO Class V cleanroom.
Baxa UK launches a full line of enteral syringes with connectors that directly fit feeding lines. The syringes’ distinctive purple plunger fits the color coding for enteral products in Europe.
2004
Baxa UK releases the CyTwoFer™ Needle for vented reconstitution of hazardous drugs.Baxa expands it corporate headquarters, opening a new 15,000 ft2 building housing the sales and marketing functions.
2005
Baxa has its first $8 million sales month.Brian Baldwin named Ernst & Young 2005 Entrepreneur of the Year.
Baxa moves to direct sales in Canada, Benelux, Finland and France.
Achieves compliance to European Waste Electrical and Electronics Equipment Directive (WEEE).
Agreement signed with Samson Medical Technologies’ SmartPak™ Sterile Bulk Bags for prescription compounding.
Baxa recognized as: Colorado Bioscience Top Company of 2005; Governor's Award for Excellence in Exporting; SBA Exporter of the Year and ColoradoBiz Top Company of the Year.
eBUG (electronic Baxa Users’ Group) launched as an online community for information sharing on Baxa products, pharmacy procedures and current issues.
2006
UK operations expand to new 10,000 ft2 facility in Radius Court, Bracknell.Baxa signs distribution agreement with CDEX Inc. for the ValiMed™ Medication Validation System.
The Skills Training, Academics and Resources (STAR) Center opens for pharmacy best practice, compliance and environmental monitoring training. The unique facility features negative and positive pressure cleanrooms, classroom and demonstration areas for hands-on and didactic training experiences.
Baxa moves to direct sales in Austria.
Baxa launches the first syringes for the US market designed exclusively for enteral feeding, featuring orange lettering and a distinctive stripe. Brand name NeoThrive® designates focus on neonatal feeding safety.
Baxa named one of the 25 best companies to work for in Colorado by the Society for Human Resource Management.
2007
Baxa launches NeoThrive® Enteral Pump, which complements the NeoThrive syringes to provide a dedicated system for enteral feeding and medication delivery.Co-marketing agreement announced with CriticalPoint™ for its online compliance training software.
Baxa announces direct sales in Switzerland.
2008
Baxa launches the MedBoard™ Medication Tracking System, as part of its line of Productivity and Compliance Tools (PACT) for managing pharmacy operations and training activities.2009
Baxa acquires ForHealth Technologies, Inc. and its IntelliFill i.v.® and IntelliFlowRxTM products for pharmacy IV room automation and management.TODAY
Baxa Corporation employs nearly 500 associates worldwide, with annual sales greater than $150 million.Right-sized product technology differentiates Baxa as a leader in efficiency and safety for fluid medication handling and administration applications.
Focus on the customer – through outstanding customer service and technical assistance, available 24 hours, 7 days a week – set Baxa apart from its competition.
Sales continue to achieve double-digit year-on-year growth levels. Increased international sales penetration is expected to grow the business exponentially over the next three to five years.
Baxa Corporation is a leading provider of devices and systems for the preparation, handling, packaging, and administration of medications. The company manufactures and markets a wide range of healthcare products used worldwide in hospital, critical care and alternate site pharmacies. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Switzerland, Italy and The Netherlands; and distribution partners worldwide.
Pictured Above (Top to Bottom):
The ExactaMix™ 2400 Compounder
Current Baxa Headquarters in Englewood, Colorado
Welcoming signage in the new STAR Center® facility
